#Does mothers really understand baby vaccine? At 10 a.m. this morning, at the Kaiyuandong Community Health Service Center in Luoyang City, Ms. Guo, a citizen, was vaccinated with the first quadrivalent meningitis combined vaccine in China, Man Haixin. Since then, the time for babies in our province to receive the tetravalent meningitis vaccine has been advanced to 3 months.
Today, four provinces and cities including Guangdong Province, Henan Province, Shanghai City, Tianjin City and other four provinces and cities simultaneously launched the first tetravalent meningococcal polysaccharide-bound vaccine Man Haixin vaccination ceremony. This is another batch of provinces and cities that have officially launched the first tetravalent meningococcal polysaccharide-bound vaccine in China after Anhui, Fujian, Guangxi, Shandong, Heilongjiang, Yunnan, Hunan, Hubei, Sichuan and other provinces and regions since July 28. So far, babies from more than a dozen provinces and cities in my country can enjoy the protection of domestic high-end meningitis vaccines.
National nationwide, tens of millions of infants and young children need meningitis vaccine to protect
meningitis, that is, epidemic cerebrospinal medulitis , which is a serious infectious disease caused by Neisseria meningitis . Humans are the only susceptible host of Neisseria meningitidis. It occurs rapidly and can be infected at all ages, which can have serious consequences for health, economy and society. Among them, the incidence rate of children under 5 years old is higher, while infants and young children aged 3 months to 12 months old are the highest.
After the founding of New China, there have been many outbreaks of meningitis in China. The most serious case in 1967, more than 160,000 people died nationwide. After the reform and opening up of , the country began to promote meningitis vaccines on a large scale. Since July 2008, meningitis vaccine has been included in the national immunization program and widely used, and the incidence of meningitis has been declining year by year.
However, in recent years, in addition to the common group A and C menopause cases, there are also W135 menopause cases with the highest mortality rate in my country. In addition, the incidence of groups B and Y also increases rapidly, and there are also hidden dangers of outbreaks. Overall, the causes of meningitis epidemic in my country are diverse, and meningitis is still a severe challenge facing the public health field.
At the same time, my country has maintained an average annual birth of more than 10 million babies for many years. This means that meningitis vaccines shoulder the important task of protecting the lives of millions of infants and young children. Chinese infants and young children need meningitis vaccines that have better safety, wider coverage of bacteria and stronger protection.
Deputy Director of the Disease Control and Immunization Program Office of Luoyang City, Henan Province Wang Wei
This time, the tetravalent meningitis binding vaccine developed by CanSino Biologics covers four bacterial groups: A, C, Y, and W135. In terms of technical technology, covalent binding of these four common pathogenic serum groups with the carrier protein CRM197 can avoid excessive use of a single vector and effectively reduce immune interference. Compared with traditional polysaccharide vaccines, combined vaccines are considered to have more advantages in protective efficacy, especially after vaccinating infants and young children between 3 months and 3 years old (47 months old), which can further enhance the immune response and bring them stronger and lasting immune protection.
in the country, meningitis vaccine is still in a period of alternation between old and new. Currently, the meningococcal vaccines that are mainstream vaccinated are polysaccharide vaccines, and can only cover two bacterial groups A and C. The meningococcal vaccines that effectively immunize the Y and W135 bacterial groups have always been blank.
CanSino Biologics tetravalent meningitis combined with the vaccine Man Haixin not only fills the gap in this field in China, but also advances the first shot to three months of age, and is vaccinated earlier for better protection. The launch of an innovative vaccine allows Chinese young menstrual age babies to be vaccinated with advanced tetravalent meningitis combined vaccines like children from developed countries.
Cansino Biologics Henan Province Manager Li Siyang
Manhaixin was independently developed byCansino Biologics for thirteen years. Since its establishment, the company has focused its innovation goals on the research and development of global advanced vaccines, and has successively developed a number of innovative vaccines with important influence in China and the world. For example, Asia's first Ebola virus disease vaccine, China's first third-generation technology new crown vaccine certified by the WHO "emergency use list" and the world's first inhaled new crown vaccine, etc.
How to get the tetravalent meningitis binding vaccine? Experts said that if the child is 3 to 5 months old, is immunized 3 times. It is recommended to start from 3 months old, with one month interval for each dose. One dose can be injected at 12 months old. If the child is 6 to 23 months old, 2 doses are immunized, 1 to 3 months apart; if the child is 2 to 3 years old (47 months old), 1 dose will be given.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-